Goldman’s up-to-$1 billion deal for Industry Ventures underscores the bank’s growth ambitions for its asset-management arm. The bank has a 10-year plan to facilitate and finance roughly $1.5 trillion ...
The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, ...
In another signal of the appetite among investors for companies applying artificial intelligence to drug discovery, Pathos AI has gathered an impressive $365 million in fourth-round financing as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback